The #1 Medical Tourism Platform since 2014
Patient Safety
Patient Safety

Andrew Syritsa

Doctor, specialist in obstetrics and gynecology, in treatment

Location

Doctor of the highest category, obstetrician-gynecologist
Conducts 3D/4D ultrasound diagnostics
Engaged in in treatment, artificial insemination, manages the organization of the clinic.

Education:

  • 2 Haapsalu School in 1978
  • UT Faculty of Medicine 1984
  • 1990 Candidate of Medical Sciences (Minsk State Medical Institute)
  • Advanced training in Finland, Sweden, Denmark, Germany, France, USA, South Africa, Australia, Switzerland, England, Iceland, Italy, the Netherlands, Austria.

Experience:

  • 1984-88 Umpi-V laboratory,
  • 1988-89 UT Department of Obstetrics and Gynecology junior researcher,
  • Doctor 1989-92, 1992-98, UT Women's Clinic doctor
  • 1998 - 2007 Associate Professor and Head of Private Practice and Doctor
  • Elite 2001 from the owner of a private clinic and a doctor
  • Gyne Clinic and Gyne Johvi owner.

Scientific activity:

  • Lectures of the University of Tartu, obstetrics and gynecology.
  • Research area: diagnostics and treatment of in, assisted ctive technologies, gynecology, diagnostic methods;
  • The first artificially conceived child was born in the Baltic States (1995).
  • He has spoken at many international conferences.
  • In 1997, the charity event "A Child in Every Family"
  • Member of the Nadezhda Foundation (1992-1996 - President of the Foundation), Member of the Bioethics Council in Estonia (1998-2001), Estonian Red Cross Order of Merit II (2006).

Publications and literature:

  • Laparoscopic evaluation of the causes of in (co-author). / / Research in Medicine. Trt, 1993;
  • Prognostic factors for (co-author). / / EA (1998) 1;
  • Transvaginal ultrasound-guided electrocoagulation in infertile patients with polycystic ovary syndrome. / / Int. J. Gynecol. And Obstetrics 63 (1998) 3;
  • Development and formation of blastocyst in normal and low-quality polypoid embryos (co-author). / / Human Reprod. 14 (1999);
  • Embryo, procedure (co-author). / / E.A., 79 (2000) 7;
  • Use of recombinant gonadotropins in (co-author). / / E.A., 79 (2000) 9;
  • The importance of implantation, outside the body (co-author S. Kalm). / / E.A., 80 (2001) 3;
  • Use of recombinant follicle-stimulating hormone containing treatment of in (co-author S. Kalm). / / E.A., 81 (2002), 5;
  • Plasma Total Homocysteine Concentrations in Infertile Women Compared with Adult Control Values (Co-authors T. Panova, T. Reitsnik). / / Clinic Chimica Acta 355 (2005);
  • The girl was born through with a rather rare disease - / incontinentia pigment / (co-author). / / E.A. 87 (2008)
  • Incontinentia pigment in femal conceived . Haller Kikkatalo-K, Peters M, Kisand K, Sõritsa Reimand T, Salumets A.
  • Am J Med Gene A. 2008 Feb 1;146A(23):3092-4
  • Poster UT Faculty of Medicine, 2010 and 2011. Scientific conferences (co-author), information published in the journal "Africa Doctor".
  • Poster presentations Inimesegeentika Society of Ireland in 2010. J. Conference (co-author)
  • 10th International Symposium on GnRH-Hypothalamic-Pituitary-Gonadal Linkage in Cancer and Reproduction. Salzburg, Austria, 6-8 February 2011, conference website (co-authored);
  • 27th Annual Meeting of the European Society of Human Reproduction and Embryology. Stockholm, Sweden, July 3-6, 2011, conference poster (co-author);
  • 11th World Congress on Endometriosis. Montpellier, France, 4-7 September 2011, Conference Poster (co-authored)